bioRxiv Science⌕ Search

bioRxiv · 10.1101/397703

Genotyping and epidemiological metadata provides new insights into population structure of Xanthomonas isolated from walnut trees

Abstract

Xanthomonas arboricola pv. juglandis (Xaj) is the etiological agent of walnut diseases affecting leaves, fruits, branches and trunks. Although this phytopathogen is widely spread in walnut producing regions and has a considerable genetic diversity, there is still a poor understanding of its epidemic behaviour. To shed some light on the epidemiology of these bacteria, 131 Xanthomonas isolates obtained from 64 walnut trees were included in this study considering epidemiological metadata such as year of isolation, bioclimatic regions, walnut cultivars, production regimes, host walnut specimen and plant organs. Genetic diversity was assessed by multilocus sequence analysis (MLSA) and dot blot hybridization patterns obtained with nine Xaj-specific DNA markers (XAJ1 - XAJ9). The results showed that Xanthomonas isolates grouped in ten distinct MLSA clusters and in 18 hybridization patterns (HP). The majority of isolates (112 out of 131) were closely related with X. arboricola strains of pathovar juglandis as revealed by MLSA (clusters I to VI) and hybridize with more than five Xaj-specific markers. Nineteen isolates clustered in four MLSA groups (clusters VII to X) which do not include Xaj strains, and hybridize to less than five markers. Taking this data together, was possible to distinguish 17 lineages of Xaj, three lineages of X. arboricola and 11 lineages of Xanthomonas sp. Some Xaj lineages appeared to be widely distributed and prevalent across the different bioclimatic regions and apparently not constrained by the other features considered. Assessment of type III effector genes and pathogenicity tests revealed that representative lineages of MLSA clusters VII to X were nonpathogenic on walnut, with exception for strain CPBF 424, making this bacterium particularly appealing to address Xanthomonas pathoadaptations to walnut.\n\nIMPORTANCEXanthomonas arboricola pv. juglandis is one of the most serious threats of walnut trees. New disease epidemics caused by this phytopathogen has been a big concern causing high economic losses on walnut production worldwide. Using a comprehensive sampling methodology to disclose the diversity of walnut infective Xanthomonas, we were able to identify a genetic diversity higher than previously reported and generally independent of bioclimatic regions and the other epidemiological features studied. Furthermore, co-colonization of the same plant sample by distinct Xanthomonas strains were frequent and suggested a sympatric lifestyle. The extensive sampling carried out resulted in a set of non-arboricola Xanthomonas sp. strains, including a pathogenic strain, therefore diverging from the nonpathogenic phenotype that have been associated to these atypical strains, generally considered to be commensal. This new strain might be particularly informative to elucidate novel pathogenicity traits and unveil pathogenesis evolution within walnut infective xanthomonads. Beyond extending the present knowledge about walnut infective xanthomonads, this study might contribute to provide a methodological framework for phytopathogen epidemiological studies, still largely disregarded.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Fernandes, C., Albuquerque, P., Cruz, L., Tavares, F.. 2018-08-22. Genotyping and epidemiological metadata provides new insights into population structure of Xanthomonas isolated from walnut trees. https://doi.org/10.1101/397703

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Lipid nanoparticle-encapsulated mRNA encoding CagW, a conserved component of the Helicobacter pylori type IV secretion system, protects mice against H. pylori challenge

Background: Roughly one person in two carries Helicobacter pylori, a pathogen classified by the World Health Organization as a group I carcinogen, and the steady loss of antibiotic efficacy has made prophylaxis an urgent rather than an optional goal. No mRNA vaccine against this organism has yet been tested in the clinic, and CagW, a conserved inner-membrane subunit of the H. pylori type IV secretion system (T4SS), has never been evaluated as an mRNA-encoded antigen. Methods: A codon-optimised construct carrying a signal peptide, the CagW coding sequence and a human IgG Fc tag was synthesised, transcribed into mRNA, encapsulated in lipid nanoparticles (LNPs) and shown to direct antigen expression in HEK293T cells. C57BL/6 mice received three intramuscular doses of CagW-Fc mRNA-LNPs (5 ug mRNA each) at 14-day intervals; animals given alum alone, luciferase mRNA-LNPs or CagW protein adsorbed to alum served as comparators. Humoral readouts (IgG, IgG1, IgG2a, IgM, IgA and secretory IgA), lymphocyte proliferation, CD4+/CD8+ subsets, intracellular IFN-{gamma}, IL-4 and IL-17A and circulating cytokines were quantified before challenge, and protection was assessed after live challenge. Results: The formulation (93.2 nm; PDI 0.13; approximately 90% encapsulation) produced CagW-specific protein in vitro. Vaccination raised high-titre CagW-specific IgG (maximal on day 42), IgM and mucosal sIgA, and drove Th1/Th2-type cellular activation (IL-2, IL-4, IL-12, IFN-{gamma} and IL-17A). After challenge, immunised animals carried markedly fewer gastric bacteria and showed lower urease activity than controls. Conclusions: CagW-Fc mRNA-LNPs are therefore a credible mRNA vaccine platform for H. pylori and warrant further preclinical development.

microbiology↗

Experimental evolution reveals temporally opposing roles for Csu pili during Acinetobacter baumannii respiratory infection

Multidrug-resistant (MDR) Acinetobacter baumannii is an opportunistic pathogen responsible for a wide range of infections, including ventilator-associated pneumonia, bloodstream infections, and urinary tract infections. Most studies investigating A. baumannii pulmonary pathogenesis rely on acute pneumonia models that use high bacterial inocula and do not recapitulate the prolonged infections observed in some patients. Recently, our laboratory developed a murine model of chronic pulmonary infection that enabled the identification of virulence factors specifically required for long-term lung persistence. To investigate how A. baumannii adapts during chronic pulmonary infection, we performed an experimental evolution study using this model. This approach revealed an unexpected role for the archaic chaperone-usher (Csu) pili in A. baumannii pathogenesis. At early time points, Csu expression reduced bacterial burdens in both acute and chronic pneumonia models, an effect associated with enhanced host inflammatory responses. In contrast, at later stages of chronic infection, Csu promoted bacterial persistence, potentially by facilitating adhesion to pulmonary epithelial cells. These opposing effects were conserved across two distinct A. baumannii clinical isolates. We also found that Csu contributes to bacterial colonization in a catheter-associated urinary tract infection (CAUTI) model in a strain-dependent manner. Together, these findings reveal an infection-stage-dependent role for Csu in A. baumannii pathogenesis, demonstrating that a bacterial surface structure can impair early colonization while promoting long-term persistence.

microbiology↗

A Vma13-targeted thiadiazole-succinimide disrupts V-ATPase dependent arginine-polyamine homeostasis to block Candida albicans escape from macrophages

Invasive candidiasis caused by Candida albicans is a life-threatening nosocomial infection with limited therapies and high morbidity and mortality among immunocompromised patients. Within host phagocytes, C. albicans catabolizes arginine to produce ammonia and fuels polyamine biosynthesis, which correlates with phagosomal alkalinization and yeast-to-hypha morphogenesis, facilitating macrophage escape and systemic dissemination. However, new antifungal strategies blocking this fungal escape remain scarce. Here, we characterize the thiadiazole-succinimide derivative ETSI, an arginine-dependent antifungal small molecule with minimal direct growth inhibition under arginine-free conditions yet robust anti-C. albicans activity in arginine-rich microenvironments mimicking the macrophage intracellular niche. Mechanistically, ETSI targets the vacuolar Vma13 to inhibit vacuolar H-ATPase (V-ATPase), dissipating vacuolar proton (H+) gradients and leading to cytoplasmic H+ retention. The accumulated cytoplasmic H+ traps intracellular ammonia and blocks its external release, while impaired vacuolar metabolite sequestration further triggers cytotoxic accumulation of arginine and polyamine metabolites. This dual metabolic perturbation suppresses phagosomal alkalinization, retains C. albicans in yeast form and blocks macrophage escape. ETSI is the first small molecule blocking C. albicans escape via disrupted Vma13/V-ATPase dependent arginine-polyamine homeostasis. This work identifies an intracellular metabolic vulnerability and establishes a niche-targeted antifungal strategy distinct from classic growth-suppressive drugs for treating invasive candidiasis.

microbiology↗